Imfinzi (durvalumab) - AstraZeneca
Yervoy (ipilimumab) - Ono Pharma, BMS
Enhertu (fam-trastuzumab deruxtecan-nxki) - Daiichi Sankyo, AstraZeneca
Opdivo (nivolumab) - Ono Pharma, BMS
Qinlock (ripretinib) - Deciphera
imatinib (YD312) - YD Global
Sutent (sunitinib) - Pfizer
https://physician-news.umiamihealth.org/sylvester-experts-explain-the-most-promising-advances-in-cancer-research-and-treatment-presented-at-asco-2022/
 
Jul 6, 2022
 
Next